| Literature DB >> 23870423 |
Rakesh Sharma1, Kelly R Biedenharn, Jennifer M Fedor, Ashok Agarwal.
Abstract
Approximately 10 to 15% of couples are impacted by infertility. Recently, the pivotal role that lifestyle factors play in the development of infertility has generated a considerable amount of interest. Lifestyle factors are the modifiable habits and ways of life that can greatly influence overall health and well-being, including fertility. Many lifestyle factors such as the age at which to start a family, nutrition, weight, exercise, psychological stress, environmental and occupational exposures, and others can have substantial effects on fertility; lifestyle factors such as cigarette smoking, illicit drug use, and alcohol and caffeine consumption can negatively influence fertility while others such as preventative care may be beneficial. The present literature review encompasses multiple lifestyle factors and places infertility in context for the couple by focusing on both males and females; it aims to identify the roles that lifestyle factors play in determining reproductive status. The growing interest and amount of research in this field have made it evident that lifestyle factors have a significant impact on fertility.Entities:
Mesh:
Year: 2013 PMID: 23870423 PMCID: PMC3717046 DOI: 10.1186/1477-7827-11-66
Source DB: PubMed Journal: Reprod Biol Endocrinol ISSN: 1477-7827 Impact factor: 5.211
Medications and their respective effects on both male and female reproductive function
| Impairment of spermatogenesis (up to one year recovery); may cause hypogonadism through pituitary–gonadal axis | |
| Reversible | |
| Impairment of spermatogenesis; erectile dysfunction | |
| Cyproterone acetate, danazol, finasteride, ketoconazole, spironolactone | Reversible |
| Impairment of spermatogenesis | |
| Ampicillin, cephalotin, cotrimoxazole, gentamycin, neomycin, nitrofurantoin, Penicillin G, spiramycin | Reversible |
| Impairment of sperm motility | |
| Cotrimoxazole, dicloxacillin, erythromycin, lincomycin, neomycin, nitrofurantoin, quinolones, tetracycline, tylosin | |
| Reversible | |
| Impairment of sperm motility | |
| Phenytoin | Reversible |
| Fertilization failure | |
| Calcium channel blockers (nifedipine) | |
| Erectile dysfunction | |
| Alpha agonists (clonidine), alpha blockers (prazocin), beta blockers, hydralazine, methyldopa, thiazide diuretics | |
| Impairment of spermatogenesis and sperm motility | |
| Mesalazine, sulfasalazine | Reversible |
| Impairment of sperm motility | |
| Quinine and its derivatives | Reversible |
| Arrest of spermatogenesis; azoospermia | |
| Irreversible | |
| Colchicines, cyclophosphamide | |
| Impairment of endometrial development | |
| Clomiphene citrate | reversible |
| Impairment of both implantation and tubal function | |
| Emergency contraceptive pills, progesterone-only pills | |
| Increase prolactin concentrations that can lead to sexual dysfunction | |
| Alpha blockers, phenothiazine, antidepressants (particularly SSRIs) | |
| Impairment of spermatogenesis and sperm motility | |
| Butyrophenones | Reversible |
| Impairment of spermatogenesis and sperm motility | |
| Niridazole | Reversible |
| Impairment of sperm concentration and motility | |
| Reversible | |
| Impairment of spermatogenesis | |
| Reversible | |
| Increase prolactin concentrations that can lead to impairment of luteal function, loss of libido, and erectile dysfunction | |
| Cimetidine, ranitidine | |
| Impair sperm motility | |
| Erectile dysfunction | |
| Suppress spermatogenesis and sperm motility | |
| Impairment of follicle rupture, ovulation, and tubal function | |
| Reversible |
Chemicals and their respective effects on both male and female reproductive function
| Inhibits binding to androgen receptor, decreased semen quality, erectile dysfunction, chromosomal abnormalities in oocyte, recurrent miscarriage, | [ | |
| | | |
| Change in hormone levels, irregular menstruation, decreased fertility, decreased semen quality, chromosomal abnormalities in sperm, altered histology of testes, decreased libido, fetal loss, miscarriage | [ | |
| Changes in hormone levels, altered puberty, altered start of menarche, endometriosis, decreased fertility, fetal loss | [ | |
| Decreased semen quality, oligozoospermia, earlier menarche, altered menstrual cycle, infertility | [ | |
| Change in hormone levels, decreased semen quality, irregular menstruation, decreased fertility, miscarriage, fetal loss | [ |